Costa L - Search Results

1

N-Telopeptide of Type I Collagen Long-Term Dynamics in Breast Cancer Patients With Bone Metastases: Clinical Outcomes and Influence of Extraskeletal Metastases.

Ferreira AR, Alho I, Shan N, Matias M, Faria M, Casimiro S, Leitzel K, Ali S, Lipton A, Costa L. Ferreira AR, et al. Among authors: costa l. Oncologist. 2016 Dec;21(12):1418-1426. doi: 10.1634/theoncologist.2015-0527. Epub 2016 Aug 17. Oncologist. 2016. PMID: 27534575 Free PMC article.

2

Biochemical markers of bone turnover in patients with metastatic bone disease.

Demers LM, Costa L, Chinchilli VM, Gaydos L, Curley E, Lipton A. Demers LM, et al. Among authors: costa l. Clin Chem. 1995 Oct;41(10):1489-94. Clin Chem. 1995. PMID: 7586522

3

Bone markers in osteoporosis and malignancy.

Lipton A, Costa L, Demers LM. Lipton A, et al. Among authors: costa l. Can J Oncol. 1995 Dec;5 Suppl 1:11-5. Can J Oncol. 1995. PMID: 8853519

4

Effect of the potent aromatase inhibitor fadrozole hydrochloride (CGS 16949A) in postmenopausal women with breast carcinoma.

Costa LA, Kopreski MS, Demers LM, Chinchilli VM, Santen RJ, Harvey HA, Lipton A. Costa LA, et al. Cancer. 1999 Jan 1;85(1):100-3. doi: 10.1002/(sici)1097-0142(19990101)85:1<100::aid-cncr14>3.0.co;2-5. Cancer. 1999. PMID: 9921980

5

Markers of bone resorption in patients treated with pamidronate.

Lipton A, Demers L, Curley E, Chinchilli V, Gaydos L, Hortobagyi G, Theriault R, Clemens D, Costa L, Seaman J, Knight R. Lipton A, et al. Among authors: costa l. Eur J Cancer. 1998 Dec;34(13):2021-6. doi: 10.1016/s0959-8049(98)00277-9. Eur J Cancer. 1998. PMID: 10070304

6

Biochemical markers and skeletal metastases.

Demers LM, Costa L, Lipton A. Demers LM, et al. Among authors: costa l. Cancer. 2000 Jun 15;88(12 Suppl):2919-26. doi: 10.1002/1097-0142(20000615)88:12+<2919::aid-cncr7>3.0.co;2-z. Cancer. 2000. PMID: 10898335 Review.

7

Bone markers in the management of metastatic bone disease.

Lipton A, Costa L, Ali SM, Demers LM. Lipton A, et al. Among authors: costa l. Cancer Treat Rev. 2001 Jun;27(3):181-5. doi: 10.1053/ctrv.2000.0212. Cancer Treat Rev. 2001. PMID: 11417969 Review.

8

Safety and efficacy of bisphosphonates beyond 24 months in cancer patients.

Ali SM, Esteva FJ, Hortobagyi G, Harvey H, Seaman J, Knight R, Costa L, Lipton A. Ali SM, et al. Among authors: costa l. J Clin Oncol. 2001 Jul 15;19(14):3434-7. doi: 10.1200/JCO.2001.19.14.3434. J Clin Oncol. 2001. PMID: 11454892 Clinical Trial.

9

Use of markers of bone turnover for monitoring bone metastases and the response to therapy.

Lipton A, Costa L, Ali S, Demers L. Lipton A, et al. Among authors: costa l. Semin Oncol. 2001 Aug;28(4 Suppl 11):54-9. doi: 10.1016/s0093-7754(01)90233-7. Semin Oncol. 2001. PMID: 11544577 Review.

10

Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status.

Costa L, Demers LM, Gouveia-Oliveira A, Schaller J, Costa EB, de Moura MC, Lipton A. Costa L, et al. Among authors: costa eb. J Clin Oncol. 2002 Feb 1;20(3):850-6. doi: 10.1200/JCO.2002.20.3.850. J Clin Oncol. 2002. PMID: 11821470

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,481 results

Search Page

Filters